152 related articles for article (PubMed ID: 10966979)
41. Clinical efficacy of the gonadotropin-releasing hormone antagonist, ganirelix, in Korean women undergoing controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer with recombinant follicle-stimulating hormone.
Moon SY; Ku SY; Kim SM; Jee BC; Suh CS; Choi YM; Kim JG; Kim SH
J Obstet Gynaecol Res; 2005 Jun; 31(3):227-35. PubMed ID: 15916659
[TBL] [Abstract][Full Text] [Related]
42. Contemporary pharmacological manipulation in assisted reproduction.
Huirne JA; Lambalk CB; van Loenen AC; Schats R; Hompes PG; Fauser BC; Macklon NS
Drugs; 2004; 64(3):297-322. PubMed ID: 14871171
[TBL] [Abstract][Full Text] [Related]
43. The place of gonadotrophin-releasing hormone antagonists in reproductive medicine.
Howles CM
Reprod Biomed Online; 2002; 4 Suppl 3():64-71. PubMed ID: 12470569
[TBL] [Abstract][Full Text] [Related]
44. Efficacy of low-dose human chorionic gonadotropin (hCG) in a GnRH antagonist protocol.
Koichi K; Yukiko N; Shima K; Sachiko S
J Assist Reprod Genet; 2006 May; 23(5):223-8. PubMed ID: 16786420
[TBL] [Abstract][Full Text] [Related]
45. Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation.
European and Middle East Orgalutran Study Group
Hum Reprod; 2001 Apr; 16(4):644-51. PubMed ID: 11278211
[TBL] [Abstract][Full Text] [Related]
46. Comparisons of different dosages of gonadotropin-releasing hormone (GnRH) antagonist, short-acting form and single, half-dose, long-acting form of GnRH agonist during controlled ovarian hyperstimulation and in vitro fertilization.
Hsieh YY; Chang CC; Tsai HD
Taiwan J Obstet Gynecol; 2008 Mar; 47(1):66-74. PubMed ID: 18400585
[TBL] [Abstract][Full Text] [Related]
47. The role of GnRH antagonists in assisted reproduction.
Barri PN; Martinez F; Coroleu B; Tur R
Reprod Biomed Online; 2002; 5 Suppl 1():14-9. PubMed ID: 12537777
[TBL] [Abstract][Full Text] [Related]
48. [Comparison of GnRH agonists and antagonists in an ovular donation program].
Saucedo de la Llata E; Moraga Sánchez MR; Batiza Reséndiz V; Santos Haliscak R; Galache Vega P; Hernández Ayup S
Ginecol Obstet Mex; 2004 Feb; 72():53-6. PubMed ID: 15216901
[TBL] [Abstract][Full Text] [Related]
49. Use of GnRH antagonists in ovarian stimulation for assisted reproductive technologies compared to the long protocol. Meta-analysis.
Ludwig M; Katalinic A; Diedrich K
Arch Gynecol Obstet; 2001 Nov; 265(4):175-82. PubMed ID: 11789740
[TBL] [Abstract][Full Text] [Related]
50. GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis.
Griesinger G; Diedrich K; Devroey P; Kolibianakis EM
Hum Reprod Update; 2006; 12(2):159-68. PubMed ID: 16254001
[TBL] [Abstract][Full Text] [Related]
51. A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist/rFSH in women pretreated with oral contraceptives before in vitro fertilization.
Barmat LI; Chantilis SJ; Hurst BS; Dickey RP
Fertil Steril; 2005 Feb; 83(2):321-30. PubMed ID: 15705369
[TBL] [Abstract][Full Text] [Related]
52. Recombinant gonadotrophins associated with GnRH antagonist (cetrorelix) in ovarian stimulation for ICSI: comparison of r-FSH alone and in combination with r-LH.
Levi-Setti PE; Cavagna M; Bulletti C
Eur J Obstet Gynecol Reprod Biol; 2006 Jun; 126(2):212-6. PubMed ID: 16377062
[TBL] [Abstract][Full Text] [Related]
53. Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle.
Kahraman K; Berker B; Atabekoglu CS; Sonmezer M; Cetinkaya E; Aytac R; Satiroglu H
Fertil Steril; 2009 Jun; 91(6):2437-44. PubMed ID: 18555238
[TBL] [Abstract][Full Text] [Related]
54. [GnRH antagonist (Orgalutran) for prevention of premature LH surges during controlled ovarian hyperstimulation].
Vladimirov Ia
Akush Ginekol (Sofiia); 2001; 40(4):21-6. PubMed ID: 11803865
[TBL] [Abstract][Full Text] [Related]
55. Gonadotrophin-releasing hormone antagonists: will they replace the agonists?
Felberbaum RE; Diedrich K
Reprod Biomed Online; 2003; 6(1):43-53. PubMed ID: 12626142
[TBL] [Abstract][Full Text] [Related]
56. [GnRH antagonists in IVF].
Olivennes F; Fanchin R; Lédée N; Righini C; Bouchard P; Frydman R
J Gynecol Obstet Biol Reprod (Paris); 2001 Nov; 30(7 Pt 1):657-62; discussion 662-3. PubMed ID: 11917361
[TBL] [Abstract][Full Text] [Related]
57. Gonadotropin-releasing hormone antagonists for assisted reproductive techniques: are there clinical differences between agents?
Griesinger G; Felberbaum RE; Schultze-Mosgau A; Diedrich K
Drugs; 2004; 64(6):563-75. PubMed ID: 15018588
[TBL] [Abstract][Full Text] [Related]
58. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology.
Al-Inany HG; Youssef MA; Aboulghar M; Broekmans F; Sterrenburg M; Smit J; Abou-Setta AM
Cochrane Database Syst Rev; 2011 May; (5):CD001750. PubMed ID: 21563131
[TBL] [Abstract][Full Text] [Related]
59. In-vitro maturation versus IVF with GnRH antagonist for women with polycystic ovary syndrome: treatment outcome and rates of ovarian hyperstimulation syndrome.
Das M; Son WY; Buckett W; Tulandi T; Holzer H
Reprod Biomed Online; 2014 Nov; 29(5):545-51. PubMed ID: 25262236
[TBL] [Abstract][Full Text] [Related]
60. Is earlier administration of human chorionic gonadotropin (hCG) associated with the probability of pregnancy in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone (GnRH) antagonists? A prospective randomized trial.
Kyrou D; Kolibianakis EM; Fatemi HM; Tarlatzis BC; Tournaye H; Devroey P
Fertil Steril; 2011 Nov; 96(5):1112-5. PubMed ID: 21924414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
